Signodap 10 Tablet
Marketer
Signum Drug Company
Salt Composition
Dapagliflozin (10mg)
Overview Signodap 10 Tablet
Glimepiride 10mg tablets are prescribed, either independently or alongside other medications, to manage type 2 diabetes. This medication assists in regulating elevated blood glucose levels associated with diabetes, thereby mitigating the risk of severe diabetic complications and contributing to heart disease prevention. Glimepiride 10mg tablets can be administered with or without food, at any point in the day, but consistent daily timing is recommended. Dosage should be determined by your physician; discontinuation should only occur under medical supervision, as abrupt cessation can lead to elevated blood sugar and increased risk of serious complications like nephropathy and vision impairment. This medication forms part of a comprehensive treatment strategy encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections. It can induce fluid loss; increased fluid intake is advised to avoid dehydration. Practicing good hygiene helps reduce the likelihood of genital fungal infections. Prior to commencing treatment, patients with kidney or liver dysfunction, urinary tract infections, or those using diuretics should inform their physician. Pregnant or lactating individuals should also seek medical counsel before use. Excessive alcohol consumption should be avoided, as it might heighten the incidence of side effects. Regular blood glucose monitoring is crucial while taking this medicine.
Uses of Signodap 10 Tablet
Managing Type 2 diabetes
Major Benefits of Signodap 10 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Signodap 10 Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Signodap 10 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Signodap 10 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Signodap 10 Tablets can be consumed with or without food, though consistent timing is recommended.
How Signodap 10 Tablet works:
Signodap 10 Tablet helps manage blood sugar levels. Its mechanism of action involves eliminating excess glucose via urinary excretion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Signodap 10 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Signodap 10 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Signodap 10 Tablet use are likely incompatible. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely refrain from using Signodap 10 Tablet due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Signodap 10 Tablets pose no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Signodap 10 Tablet :
Should you forget a dose of Signodap 10 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Signodap 10 Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |




